PEN
Penumbra, Inc.
Is PEN Halal?
Medical-device company for stroke and blood-clot removal — generally permissible healthcare activity with passing current asset ratios and disclosed low interest income.
What You Should Know
Penumbra, Inc. designs and sells interventional medical devices for stroke, vascular and rehabilitation applications. Its March 31, 2026 Form 10-Q reports $1,898.438 million of assets, no identified interest-bearing debt, $241.289 million of cash, $374.371 million of available-for-sale debt securities, $183.295 million of accounts receivable and $374.758 million of first-quarter revenue. Debt/assets is 0.00%, liquidity/assets is 32.43%, receivables-plus-cash/assets is 22.36% and disclosed investment income interest/revenue is 1.30%. Healthcare devices are generally permissible, while customer and product-level classification remains incomplete.
⚠️ Concerns
- •Debt/assets is 0.00% and should be rechecked under market-cap methods
- •Liquidity/assets is 32.43%, close to the examined asset limit
- •Disclosed investment income interest is 1.30% of revenue; follow the chosen purification guidance
- •Medical-device products require product-level safety and ethical review
- •Re-screen as cash, securities, receivables and product mix change
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
0 / 1,898.438
615.66 / 1,898.438
424.584 / 1,898.438
4.871 / 374.758
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 0.00%, liquidity/assets is 32.43%, receivables plus cash/assets is 22.36% and interest income/revenue is 1.30%, below the examined limits; activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 0.00%, liquidity/assets is 32.43% and receivables plus cash/assets is 22.36%, below the examined MSCI limits; activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets and liquidity/assets are below the examined Malaysia SAC limits; activity remains incomplete and this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored, so market-cap denominator methods are not estimated from a current spot price.
Business-activity disclosure
Penumbra designs and sells interventional medical devices for stroke, vascular and rehabilitation applications. Healthcare devices are generally permissible, while product, customer and end-use disclosure remains methodology-dependent.
Limitation: The filing does not allocate every product, customer or end use into a universal prohibited-activity numerator.
Purification
Penumbra discloses $4.871 million of investment income interest, but no scholar-approved purification percentage is inferred.
Inputs, assumptions and primary sources
- Amounts are USD millions from Penumbra's March 31, 2026 Form 10-Q.
- No interest-bearing debt is identified in the extracted balance-sheet facts; operating leases are excluded.
- Cash and cash equivalents are $241.289 million. Available-for-sale debt securities are $374.371 million and are included as identifiable interest-bearing securities.
- Accounts receivable, net is $183.295 million and first-quarter revenue is $374.758 million.
- Investment income interest is $4.871 million; the filing does not provide a universal prohibited-revenue numerator for products, customers or end uses.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →